US Bancorp’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
3,065
+1,300
| +74% | +$69.4K | ﹤0.01% | 2160 |
|
|
2025
Q1 | $71.4K | Buy |
1,765
+46
| +3% | +$1.86K | ﹤0.01% | 2555 |
|
|
2024
Q4 | $47.8K | Buy |
1,719
+8
| +0.5% | +$223 | ﹤0.01% | 2756 |
|
|
2024
Q3 | $49.1K | Sell |
1,711
-50
| -3% | -$1.44K | ﹤0.01% | 2746 |
|
|
2024
Q2 | $41.3K | Buy |
1,761
+48
| +3% | +$1.13K | ﹤0.01% | 2762 |
|
|
2024
Q1 | $43.3K | Sell |
1,713
-1,464
| -46% | -$37K | ﹤0.01% | 2772 |
|
|
2023
Q4 | $74.2K | Buy |
3,177
+907
| +40% | +$21.2K | ﹤0.01% | 2469 |
|
|
2023
Q3 | $115K | Sell |
2,270
-1,391
| -38% | -$70.4K | ﹤0.01% | 2082 |
|
|
2023
Q2 | $171K | Buy |
3,661
+436
| +14% | +$20.4K | ﹤0.01% | 1925 |
|
|
2023
Q1 | $123K | Sell |
3,225
-4,208
| -57% | -$161K | ﹤0.01% | 2091 |
|
|
2022
Q4 | $407K | Buy |
7,433
+1,892
| +34% | +$104K | ﹤0.01% | 1497 |
|
|
2022
Q3 | $189K | Buy |
5,541
+3,286
| +146% | +$112K | ﹤0.01% | 1873 |
|
|
2022
Q2 | $21K | Buy |
2,255
+879
| +64% | +$8.19K | ﹤0.01% | 3002 |
|
|
2022
Q1 | $20K | Buy |
1,376
+276
| +25% | +$4.01K | ﹤0.01% | 3042 |
|
|
2021
Q4 | $23K | Hold |
1,100
| – | – | ﹤0.01% | 3008 |
|
|
2021
Q3 | $25K | Sell |
1,100
-1,931
| -64% | -$43.9K | ﹤0.01% | 2990 |
|
|
2021
Q2 | $75K | Sell |
3,031
-969
| -24% | -$24K | ﹤0.01% | 2452 |
|
|
2021
Q1 | $116K | Buy |
+4,000
| New | +$116K | ﹤0.01% | 2184 |
|
|
2020
Q3 | – | Sell |
-750
| Closed | -$19K | – | 3611 |
|
|
2020
Q2 | $19K | Hold |
750
| – | – | ﹤0.01% | 2780 |
|
|
2020
Q1 | $16K | Buy |
+750
| New | +$16K | ﹤0.01% | 2781 |
|